That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only ...

Research reveals rise in AFib among younger people. Learn the warning signs, risk factors and how to protect your heart ...

Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Cardiac ablation has emerged as a transformative medical procedure for patients struggling with irregular heart rhythms particularly atrial fibrillation AFib By targeting and eliminating problematic a ...

Though the Ultrahuman Ring Air is primarily a sleep and recovery tracker, it also offers basic exercise monitoring with ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

Promising results show that abelacimab could revolutionize anticoagulation therapy by slashing bleeding risks without compromising stroke protection for patients with atrial fibrillation. Study ...